Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms
COPD, Diabetes, Hypertension

About this trial
This is an interventional treatment trial for COPD focused on measuring COPD, Intervention, Motivational Interviewing, Cognitive Restructuring, Diabetes, Hypertension
Eligibility Criteria
Inclusion Criteria:
Patients will be included in the pilot study if they meet any of the following criteria:
- Low medication adherence for COPD, hypertension, or diabetes medications (score <4.5 on the Medication Adherence Rating Scale, or adherence rate <70% as measured by electronic dose monitoring at study month 15);
- Endorsement of any maladaptive illness belief on the Brief Illness Perceptions Questionnaire for COPD, HTN, or DM;
- Endorsement of any maladaptive medication belief on the Brief Medication Questionnaire for COPD, HTN, or DM.
Exclusion Criteria:
- Adequate medication adherence for COPD
- Adequate medication adherence for hypertension
- Adequate medication adherence for diabetes medications
Score ≥4.5 on Medication Adherence Rating Scale, or adherence rate ≥70% as measured by electronic dose monitoring at Study Month 15.
Sites / Locations
- Northwestern University
- Icahn School of Medicine at Mount Sinai
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention
Control
Intervention group - Cognitive Restructuring, Motivational Interviewing, and Multi-Medication Adherence. The pilot intervention is comprised of three educational sessions for individual study patients, conducted by interventionist with a master's degree in psychology with cognitive behavioral therapy training. The topics addressed in the sessions are as follows: Review of COPD medication inhaler technique, psychoeducation on maladaptive beliefs and emotional response.
Control group - Supportive counseling for comorbidity management